Adam Veness Insider Trades & Stock Holdings

SVP, General Counsel and Sec. · Dianthus Therapeutics, Inc. · Latest filing Jun 17, 2026

Adam Veness, SVP, General Counsel and Sec. at Dianthus Therapeutics, Inc. has 2 Form 4 trades on file since Jun 17, 2026. Latest filing: disposed of 30K shares of $DNTH on Jun 17, 2026.

Trades on file

2

Open-market bought

$0

Open-market sold

$0

Net open-market

$0

Latest filing

Jun 17, 2026

All insider trades by Adam Veness

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 17, 2026	$DNTH	Sell (Option exercise)	30K	$0	—			+10.9%	+29.0%		SVP, General Counsel and Sec.		—
Jun 17, 2026	$DNTH	Buy (Option exercise)	30K	$17.88	$536.40K			+10.9%	+29.0%		SVP, General Counsel and Sec.		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Adam Veness traded

• $DNTH

Frequently asked questions

What was Adam Veness's latest insider trade?

disposed of 30K shares of $DNTH on Jun 17, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.